首页> 外国专利> New expression vector for producing annexin V, useful as anticoagulant, includes kanamycin resistance gene, also Escherichia coli containing the vector

New expression vector for producing annexin V, useful as anticoagulant, includes kanamycin resistance gene, also Escherichia coli containing the vector

机译:用于产生可用作抗凝剂的膜联蛋白V的新表达载体包括卡那霉素抗性基因,以及含有该载体的大肠杆菌

摘要

Expression vector (A) for production of annexin V (I), is new. Expression vector (A) comprising: (a) at least the components of pBR322 or pKK223-3 that are required for replication; (b) an expression region comprising, in sequence in the reading direction, a promoter (P1), a repressor-specific binding site (X), a prokaryotic ribosome-binding site (RBS), cloning site for the gene for annexin V (I), and at least one transcriptional terminator; and (c) at least one kanamycin resistance gene controlled by promoter P2. An independent claim is also included for Escherichia colicells that contain (A). ACTIVITY : Anticoagulant. No biological data is given. MECHANISM OF ACTION : (I) binds to phosphatidylserine.
机译:用于产生膜联蛋白V(I)的表达载体(A)是新的。表达载体(A),其包含:(a)复制所需的至少pBR322或pKK223-3的成分; (b)在阅读方向上依次包含启动子(P1),阻遏物特异性结合位点(X),原核核糖体结合位点(RBS),膜联蛋白V基因的克隆位点的表达区( I),和至少一个转录终止子; (c)至少一个由启动子P2控制的卡那霉素抗性基因。对于包含(A)的大肠杆菌细胞,也包括独立权利要求。活动:抗凝剂。没有给出生物学数据。作用机理:(I)结合磷脂酰丝氨酸。

著录项

  • 公开/公告号DE20221079U1

    专利类型

  • 公开/公告日2005-02-03

    原文格式PDF

  • 申请/专利权人 RESPONSIF GMBH;

    申请/专利号DE2002221079U

  • 发明设计人

    申请日2002-12-16

  • 分类号C12N15/70;

  • 国家 DE

  • 入库时间 2022-08-21 22:00:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号